1. Home
  2. GPC vs MDGL Comparison

GPC vs MDGL Comparison

Compare GPC & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genuine Parts Company

GPC

Genuine Parts Company

HOLD

Current Price

$103.47

Market Cap

14.4B

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$546.89

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPC
MDGL
Founded
1928
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Automotive Aftermarket
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.4B
12.0B
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
GPC
MDGL
Price
$103.47
$546.89
Analyst Decision
Buy
Strong Buy
Analyst Count
6
12
Target Price
$145.67
$674.45
AVG Volume (30 Days)
2.1M
335.0K
Earning Date
04-21-2026
04-30-2026
Dividend Yield
4.11%
N/A
EPS Growth
N/A
41.32
EPS
0.47
N/A
Revenue
$24,300,141,000.00
$180,133,000.00
Revenue This Year
$5.46
$58.28
Revenue Next Year
$3.80
$46.80
P/E Ratio
$219.98
N/A
Revenue Growth
3.46
N/A
52 Week Low
$96.08
$265.00
52 Week High
$151.57
$615.00

Technical Indicators

Market Signals
Indicator
GPC
MDGL
Relative Strength Index (RSI) 36.88 74.28
Support Level $96.08 $535.33
Resistance Level $106.48 $572.20
Average True Range (ATR) 2.71 26.99
MACD 1.20 11.83
Stochastic Oscillator 70.92 82.48

Price Performance

Historical Comparison
GPC
MDGL

About GPC Genuine Parts Company

Genuine Parts sells aftermarket automotive parts (60% of sales) and industrial products (40% of sales) in the United States and internationally. The automotive segment primarily acts as a distributor to its network of 9,800 global retail locations, of which about two-thirds are independently owned and operated. We estimate Genuine serves around 6,000 retail locations in the US operating under the Napa Auto Parts brand, with about 80% of end-market sales derived from professional customers. Its industrial segment, primarily operating under the Motion name in the United States, is a leading distributor of bearings, power transmission, and other industrial products to more than 200,000 maintenance, repair, and original equipment manufacturer customers.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: